Similar articles

• Paradoxical ventricular tachycardia and fibrillation after intravenous bretylium therapy. Report of two cases.

  Anderson JL, Popat KD, Pitt B. Anderson JL, et al. Arch Intern Med. 1981 May;141(6):801-2. Arch Intern Med. 1981. PMID: 7235792
• [Use of bretylium tosylate in ventricular fibrillation].

  Arcidiacono R. Arcidiacono R. Clin Ter. 1978 Feb 15;84(3):253-66. Clin Ter. 1978. PMID: 346298 Clinical Trial. Italian. No abstract available.
• Drug therapy: bretylium.

  Koch-Weser J. Koch-Weser J. N Engl J Med. 1979 Mar 1;300(9):473-7. doi: 10.1056/NEJM197903013000905. N Engl J Med. 1979. PMID: 366419 Review. No abstract available.
• Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction.

  Dhurandhar RW, Pickron J, Goldman AM. Dhurandhar RW, et al. Heart Lung. 1980 Mar-Apr;9(2):265-70. Heart Lung. 1980. PMID: 6898604
• Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.

  Heissenbuttel RH, Bigger JT Jr. Heissenbuttel RH, et al. Ann Intern Med. 1979 Aug;91(2):229-38. doi: 10.7326/0003-4819-91-2-229. Ann Intern Med. 1979. PMID: 380436 Review.